A secondarv local and splenic cell-mediated immune response was observed and compared to the primary response. Previous studies have demonstrated cell-mediated immunity (CMI) by lymphocytes from bronchopulmonary washings and have shown that its appearance is to a large extent inedpendent ot' splenic CMI. This study evaluated the secondary as compared to the primary response, with respect to both cellular and humoral immune responses. Guinea pigs were immunized with influenza virus vaccine either nasallv or parenterallv. booster immunizations were given by the same route, and animals were killed at various times af'ter immunization or booster. The inhibition of' macrophage migration was used to assess CMI. As in previous studies, local application of' antigen led to mainly local appearance of' CMI, whereas parenteral immunization led to mainly systemic CMI. Both pulmonarv and splenic lymphocvtes showed an inhibition of' macrophage migration that appeared 2 to 3 davs sooner after the booster, as compared to the primary immunization. There was no evidence, however, f'or the earlier production or increased amount of' antibody in the bronchial secretions in the boosted animals. The results suggest that pulmonary as well as splenic T lymphocytes exhibit memory, but that pulmonary B lymphocytes do not.
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Previous studies have demonstrated the presence of cell-mediated immunity (CMI) on secretory surf'aces and have shown that local CMI can be stimulated independently of' systemic CMI (5, 14, 15) . The appearance of' CMI in the respiratory tract and spleen is dependent on the route of' immunization. Thus, respiratory tract CMI is more effectively stimulated by administration of' the antigen into the respiratory tract, whereas splenic CMI is better stimulated by subcutaneous administration.
Using the inhibition of' macrophage migration, CMI has previously been evaluated in the respiratory tract mainly with respect to the primary response, although a secondary response has been demonstrated by Nash and Holle (8) more eff'ectively produced by local application of the antigen, whereas stimulation in the spleen is more effectively evoked by parenteral administration of antigen.
The booster response was characterized by the earlier appearance of inhibition of macrophage migration (IMM) than the primary response (Fig. 2) . In animals immunized by nose drops, no inhibition was found 2 to 3 days after primary immunization in the lungs, but an MI of 25%c was seen 2 to 3 days after boosting (P < 0.01). Booster immunizations were carried out 43 to 45 days after the primary. At that time, animals receiving no booster showed no residual inhibition by their pulmonary cells. There was no significant difference in the intensity or duration of the booster as compared to the primary response.
Again, comparing the spleens of guinea pigs immunized subcutaneously, the primary response showed an MI of 3% 2 to 3 days postimmunization, whereas the booster response showed an MI of 24% after 2 to 3 days (P < 0.01). And again, the primary response in the spleen had disappeared by 43 days, the time of the boosting. The intensity and duration of' both responses were the same. Humoral antibody. Production of influenzaneutralizing antibody in the bronchial washings and serum of both locally and systemically immunized animals was dependent on route of immunization (Fig. 3) . Antibody in bronchial washings was found only after local immunization. Similarly, the mean maximal serum-neutralizing antibody in guinea pigs given footpad injections was 1:64, whereas that in nasally immunized animals was 1:6. After primary immunization, antibody was first detected at 6 to 7 days in the bronchial washings of nasally immunized animals, whereas after booster immunization, antibody was detectable at 2 to 3 days. However, the mean antibody titer was no higher than that remaining in the guinea pigs 45 days after the primary immunization, so this cannot be taken as evidence for a memory system. In addition, the primary and secondary responses were not of statistically different intensity in the bronchial washings of guinea pigs given nose drops (Fig. 4) .
In the bronchial washings of guinea pigs given footpad injections, no antibody was detectable after primary immunization, whereas neutralizing antibody was found, although at low titers, after the booster (differences were not statistically significant).
DISCUSSION
The results of this study confirm previous findings from this laboratory that CMI and antibody production in the respiratory tract route of immunization. Rabbits immunized subcutaneously with BCG developed dermal tuberculin sensitivity, whereas rabbits immunized intravenously did not. Alveolar cells from subcutaneously immunized rabbits showed little inhibition by mycobacterial antigens in the migration inhibition test, whereas alveolar cells from rabbits immunized intravenously were consistently inhibited by these antigens. Kawai et al. (6) showed that alveolar wash cells from rabbits immunized intratracheally with Micropolyspora faeni were able to inhibit macrophage migration in the presence of antigen.
Although local production of CMI in the respiratory tract has been established (15) This could be due either to sensitized T lymphocytes produced locally in the lung or to sensitized lymphocytes migrating to the lungs, possibly related to the inflammation set up in response to the antigen. Studies to differentiate between these alternatives are underway, but the time course of the response favors the former explanation, because any inflammation after administration of killed influenza virus would be very short-lived. Thus, memory seems to be exhibited by both systemic and secretory T lymphocytes.
T lymphocyte memory in the humoral response has been extensively studied. Although it has been shown that T cells involved in the enhancement of antibody production have the capacity for memory (10, 13) , it is not known whether these T cells are the same T cells involved in CMI.
Systemic memory in T lymphocytes active in CMI has previously been demonstrated in second-set graft rejections, a presumed function of CMI (12) . However, it has been difficult to demonstrate directly T lymphocyte memory because of the unavailability of suitable in vitro tests.
The development of the IMM test has provided a method. Nash and Holle (8) have shown a secondary response in bronchial washing, spleen, and in peritoneal exudate cells after secondary low-dose local stimulation with 2,4-dinitrophenol-HGG. Cells of all three populations did not inhibit migration of macrophages until 1 week after primary immunization but inhibited migration 4 days after secondary challenge, memory being indicated by the earlier appearance of IMM. Similarly, we have shown that the appearance of IMM is more rapid in both bronchial washing cells from locally boosted animals and spleen cells from parenterally boosted animals. Neither a heightened nor a more prolonged response was observed. The earlier appearance of CMI in the lower respiratory tract after the second exposure to the antigen may be important in protection against infections of this secretory surface. When influenza virus infection occurs, the difference of few days between the onset of CMI in the sensitized and nonsensitized individual might be a determining factor in whether clinical disease occurs or not. Both primary and secondary local CMI was best stimulated by nose-drop immunization.
Antibody did not appear earlier and was not detected in higher titer in the bronchial washings of guinea pigs given either nose drops or footpad injections, suggesting that secretory B lymphocytes have no capacity for memory. This 862 GADOL, JOHNSON, AND WALDMAN agrees with a study in humans showing no evidence of a heightened or earlier response after secondary local administration of inactivated poliovirus vaccine in the nasopharynx (9) .
In contrast, another study suggested the presence of respiratory tract memory, because a nonimmunizing dose of inactivated rhinovirus vaccine given intranasally elicited a significant local antibody response in men previously infected or vaccinated (1). It is possible that the different results depend on the antigen used, or in the timing of the booster immunization. It is possible that a longer interval between the primary and secondary immunization might have resulted in an evident memory response.
Local administration of antigen produced neutralizing antibody in both bronchial washings and serum, whereas parenteral immunization caused a high serum-neutralizing antibody response but very little antibody production in bronchial washings. Thus, although systemic introduction of antigen initiates both a high CMI response in the spleen and high antibody titers in the serum, there is poor stimulation of both CMI and antibody production in the respiratory tract-possibly important mechanisms in host defenses against viral infections of the respiratory tract.
